| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| GADD45B | LOC101071689 | ENSTRUP00000032612 | ENSTRUP00000022939 | Growth arrest and DNA damage inducible beta. | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2a. | 0.581 |
| GADD45B-2 | LOC101071689 | ENSTRUP00000057537 | ENSTRUP00000022939 | Growth arrest and DNA damage inducible beta. | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2a. | 0.579 |
| H2TAS4_TAKRU | LOC101065744 | ENSTRUP00000086309 | ENSTRUP00000083792 | Myozenin 2a. | Uncharacterized protein. | 0.766 |
| H2TAS4_TAKRU | LOC101071689 | ENSTRUP00000086309 | ENSTRUP00000022939 | Myozenin 2a. | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2a. | 0.639 |
| H2TAS4_TAKRU | smyd1 | ENSTRUP00000086309 | ENSTRUP00000083289 | Myozenin 2a. | SET and MYND domain containing 1b. | 0.766 |
| LOC101065744 | H2TAS4_TAKRU | ENSTRUP00000083792 | ENSTRUP00000086309 | Uncharacterized protein. | Myozenin 2a. | 0.766 |
| LOC101065744 | LOC101071689 | ENSTRUP00000083792 | ENSTRUP00000022939 | Uncharacterized protein. | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2a. | 0.612 |
| LOC101065744 | LOC101073019 | ENSTRUP00000083792 | ENSTRUP00000036313 | Uncharacterized protein. | Myozenin 2b. | 0.766 |
| LOC101071689 | GADD45B | ENSTRUP00000022939 | ENSTRUP00000032612 | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2a. | Growth arrest and DNA damage inducible beta. | 0.581 |
| LOC101071689 | GADD45B-2 | ENSTRUP00000022939 | ENSTRUP00000057537 | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2a. | Growth arrest and DNA damage inducible beta. | 0.579 |
| LOC101071689 | H2TAS4_TAKRU | ENSTRUP00000022939 | ENSTRUP00000086309 | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2a. | Myozenin 2a. | 0.639 |
| LOC101071689 | LOC101065744 | ENSTRUP00000022939 | ENSTRUP00000083792 | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2a. | Uncharacterized protein. | 0.612 |
| LOC101071689 | LOC101073019 | ENSTRUP00000022939 | ENSTRUP00000036313 | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2a. | Myozenin 2b. | 0.639 |
| LOC101071689 | LOC105417876 | ENSTRUP00000022939 | ENSTRUP00000049262 | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2a. | Methyl-CpG binding domain protein 1b. | 0.540 |
| LOC101071689 | a1cf | ENSTRUP00000022939 | ENSTRUP00000004572 | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2a. | Apobec1 complementation factor. | 0.715 |
| LOC101071689 | rbm47 | ENSTRUP00000022939 | ENSTRUP00000061896 | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2a. | RNA binding motif protein 47. | 0.681 |
| LOC101071689 | smyd1 | ENSTRUP00000022939 | ENSTRUP00000083289 | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2a. | SET and MYND domain containing 1b. | 0.612 |
| LOC101071689 | srp19 | ENSTRUP00000022939 | ENSTRUP00000067883 | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2a. | Signal recognition particle 19. | 0.581 |
| LOC101073019 | LOC101065744 | ENSTRUP00000036313 | ENSTRUP00000083792 | Myozenin 2b. | Uncharacterized protein. | 0.766 |
| LOC101073019 | LOC101071689 | ENSTRUP00000036313 | ENSTRUP00000022939 | Myozenin 2b. | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2a. | 0.639 |
